| 1. |
News in brief… |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1083,
1997,
Page 2-2
&NA;,
Preview
|
PDF (1166KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 2. |
Issues in paediatric drug use in the US |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1083,
1997,
Page 3-3
Gill Higgins,
Preview
|
PDF (997KB)
|
|
摘要:
Approximately 75% of childhood illnesses requiring drug therapy are treated with drugs used in an off-label manner. As long as drugs can be used in this way, there will be little incentive for pharmaceutical companies to conduct controlled studies of their use in children. Accordingly, there is a dearth of information on paediatric drug use. At the 55th Annual Meeting of the American Academy of Dermatology [San Francisco, US; March 1997], specialists in paediatric care addressed some of the current issues regarding the use and availability of drugs for childhood disease in the US.
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 3. |
Looking at treatment guidelines |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1083,
1997,
Page 4-5
&NA;,
Preview
|
PDF (2164KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 4. |
Failure rates drive the costs of contraception |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1083,
1997,
Page 6-6
&NA;,
Preview
|
PDF (1138KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 5. |
Risedronic acid prevents bone loss associated with cancer therapy |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1083,
1997,
Page 7-7
&NA;,
Preview
|
PDF (1006KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 6. |
Nelfinavir in HIV infection… |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1083,
1997,
Page 8-8
&NA;,
Preview
|
PDF (1086KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 7. |
Further support for use of thrombopoietins in cancer |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1083,
1997,
Page 9-10
Robert Carlson,
Preview
|
PDF (2156KB)
|
|
摘要:
The results of a recent study of Amgen's PEG-thrombopoietin [PEG-MGDF*] have confirmed the efficacy of this agent in terms of reducing the severity and duration of thrombocytopenia in patients with cancer. The study results are a positive step in the development of Amgen's thrombopoietin product. However, specialists in the field believe that Genentech's recombinant human thrombopoietin [MGDF] is similarly effective. The 2 agents were discussed at the 4th International Congress on Biological Response Modifiers [San Antonio, US; March 1997].
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 8. |
News in brief… |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1083,
1997,
Page 10-10
&NA;,
Preview
|
PDF (1100KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 9. |
Benefits of somatropin in heart failure |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1083,
1997,
Page 11-11
&NA;,
Preview
|
PDF (1021KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 10. |
News from the 12th International Symposium on Parkinson's DiseaseLondon, UK March 1997 |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1083,
1997,
Page 12-13
&NA;,
Preview
|
PDF (2067KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
首页
